Jimenez Says Novartis Poised for Next Growth Phase

Jan. 23 (Bloomberg) -- Novartis AG Chief Executive Officer Joseph Jimenez discusses profitability and Chairman Daniel Vasella's decision to step down from the board of Europe's biggest drugmaker. He talks with Mark Barton on Bloomberg Television's "Countdown." (Source: Bloomberg)